|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Schering-Plough
Acceleron Pharma
|
|
gptkbp:CEO
|
gptkb:Robert_M._Davis
|
|
gptkbp:clinicalTrials
|
ongoing
|
|
gptkbp:competitors
|
gptkb:AstraZeneca
gptkb:Johnson_&_Johnson
gptkb:Pfizer
Novartis
|
|
gptkbp:divisions
|
gptkb:Merck_Research_Laboratories
gptkb:Merck_Manufacturing_Division
gptkb:Merck_Animal_Health
gptkb:Merck_Consumer_Care
|
|
gptkbp:employees
|
approximately 74,000
|
|
gptkbp:founded
|
1891
|
|
gptkbp:founder
|
gptkb:George_Merck
|
|
gptkbp:globalPresence
|
over 140 countries
|
|
gptkbp:headCoach
|
gptkb:Robert_M._Davis
|
|
gptkbp:headquarters
|
gptkb:New_Jersey
gptkb:Kenilworth,_New_Jersey
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Merck & Co. Inc.
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:market
|
$200 billion (2021)
|
|
gptkbp:notableFeature
|
gptkb:Lynparza
gptkb:Januvia
gptkb:Rebif
gptkb:Zetia
Gardasil
Keytruda
Belsomra
Singulair
Vaxneuvance
Vytorin
|
|
gptkbp:partnerships
|
gptkb:GSK
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
|
|
gptkbp:patentCitation
|
numerous
|
|
gptkbp:philanthropy
|
gptkb:Merck_Foundation
|
|
gptkbp:products
|
antibiotics
vaccines
oncology drugs
|
|
gptkbp:researchFocus
|
HIV/AIDS
diabetes
vaccines
cardiovascular diseases
|
|
gptkbp:revenue
|
$48.7 billion (2020)
|
|
gptkbp:stockSymbol
|
MRK
|
|
gptkbp:subsidiary
|
gptkb:Merck_Sharp_&_Dohme
|
|
gptkbp:tradedOn
|
gptkb:NYSE
|
|
gptkbp:website
|
www.merck.com
|